Chain transfer agent for addition mass polymerization of polycycloolefinic monomers

US2016289353A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016289353-A1
Application numberUS-201615086185-A
CountryUS
Kind codeA1
Filing dateMar 31, 2016
Priority dateMar 31, 2015
Publication dateOct 6, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to use of certain chain transfer agents to control molecular weight of addition mass polymerization of certain polycycloolefinic monomers. More specifically, the present invention relates to use of a series of substituted bicycloalkenes as chain transfer agents in the addition mass polymerization of a series of functionalized norbornene-type monomers. This invention also relates to compositions containing bicycloalkenes as chain transfer agents in forming “in mold” polycycloolefinic polymers by addition mass polymerization.

First claim

Opening claim text (preview).

What is claimed is: 1 . A reaction composition comprising: a compound of formula (I): wherein a is an integer from 0 to 4; b is an integer from 0 to 2a+4; each R is hydrogen, halogen, methyl, ethyl, linear or branched (C 3 -C 6 )alkyl, substituted or unsubstituted (C 3 -C 7 )cycloalkyl, (C 6 -C 10 )aryl, (C 6 -C 10 )aralkyl, methoxy, ethoxy, linear or branched (C 3 -C 6 )alkoxy, substituted or unsubstituted (C 3 -C 7 )cycloalkoxy, (C 6 -C 10 )aryloxy and (C 6 -C 10 )aralkyloxy; one or more polycyclic olefin monomers; and an organo-transition metal compound. 2 . The composition of claim 1 , wherein said one or more polycyclic olefin monomer is of formula (II): wherein: c is an integer 0, 1 or 2; R 1 , R 2 , R 3 and R 4 are the same or different and each independently of one another is selected from hydrogen, linear or branched (C 1 -C 16 )alkyl, hydroxy(C 1 -C 16 )alkyl, perfluoro(C 1 -C 12 )alkyl, (C 3 -C 12 )cycloalkyl, (C 6 -C 12 )bicycloalkyl, (C 7 -C 14 )tricycloalkyl, (C 6 -C 10 )aryl, (C 6 -C 10 )aryl(C 1 -C 3 )alkyl, perfluoro(C 6 -C 10 )aryl, perfluoro(C 6 -C 10 )aryl(C 1 -C 3 )alkyl, di(C 1 -C 2 )alkylmaleimide(C 3 -C 6 )alkyl, di(C 1 -C 2 )alkylmaleimide(C 2 -C 6 )alkoxy(C 1 -C 2 )alkyl, hydroxy, (C 1 -C 12 )alkoxy, (C 3 -C 12 )cycloalkoxy, (C 6 -C 12 )bicycloalkoxy, (C 7 -C 14 )tricycloalkoxy, (C 6 -C 10 )aryloxy(C 1 -C 3 )alkyl, (C 5 -C 10 )heteroaryloxy(C 1 -C 3 )alkyl, (C 6 -C 10 )aryloxy, (C 5 -C 10 )heteroaryloxy, (C 1 -C 6 )acyloxy, where each of the aforementioned substituents are optionally substituted with a group selected from halogen or hydroxy. 3 . The composition of claim 1 , wherein said compound of formula (I) is selected from the group consisting of: bicyclo[3.2.0]hept-6-ene; 2-methylbicyclo[3.2.0]hept-6-ene; 2,4-dimethylbicyclo[3.2.0]hept-6-ene; 2,4,6-trimethylbicyclo[3.2.0]hept-6-ene; bicyclo[4.2.0]oct-7-ene; 2-methylbicyclo[4.2.0]oct-7-ene; 3-methylbicyclo[4.2.0]oct-7-ene; 2,3-dimethylbicyclo[4.2.0]oct-7-ene; 2,3,5-trimethylbicyclo[4.2.0]oct-7-ene; 2,3,4,5-tetramethylbicyclo[4.2.0]oct-7-ene; bicyclo[5.2.0]non-8-ene; 2-methylbicyclo[5.2.0]non-8-ene; 2,5-dimethylbicyclo[5.2.0]non-8-ene; bicyclo[6.2.0]dec-9-ene; and 2-methylbicyclo[6.2.0]dec-9-ene. 4 . The composition of claim 1 , wherein said organo-transition metal compound is selected from the group consisting of: wherein Py is pyridine. 5 . The composition of claim 1 , wherein said organo-transition metal compound is selected from the group consisting of: 6 . The composition of claim 1 , wherein said organo-transition metal compound is selected from the group consisting of: trans-[Pd(NCMe)(OAc)(P(i-propyl) 3 ) 2 ]B(C 6 F 5 ) 4 , trans-[Pd(NCC(CH 3 ) 3 )(OAc)(P(i-propyl) 3 ) 2 ]B(C 6 F 5 ) 4 , trans-[Pd(OC(C 6 H 5 ) 2 )(OAc)(P(i-propyl) 3 ) 2 ]B(C 6 F 5 ) 4 , trans-[Pd(HOCH(CH 3 ) 2 )(OAc)(P(i-propyl) 3 ) 2 ]B(C 6 F 5 ) 4 , trans-[Pd(NCMe)(OAc)(P(cyclohexyl) 3 ) 2 ]B(C 6 F 5 ) 4 , Pd(OAc) 2 (P(cyclohexyl) 3 ) 2 , Pd(OAc) 2 (P(i-propyl) 3 ) 2 , Pd(OAc) 2 (P(i-propyl) 2 (phenyl)) 2 , trans-[Pd(NCMe)(OAc)(P(cyclohexyl) 2 (t-butyl)) 2 ]B(C 6 F 5 ) 4 , where OAc is OCOCH 3 . 7 . The composition of claim 1 , wherein said organo-transition metal compound is selected from the group consisting of: nickel(2,4,6-trifluoromethylphenyl) 2 ; nickel(η 6 -toluene)(pentafluorophenyl) 2 ; nickel (tetrahydrofuran) 2 (pentafluorophenyl) 2 ; [(allyl)Ni(1,4-cyclooctadiene)]PF 6 , [(crotyl)Ni(1,4-cyclooctadiene)]PF 6 ; and [(allyl)Ni(1,4-cyclooctadiene)]SbF 6 . 8 . The composition of claim 1 further comprising a compound of the formula (V): M ⊕ Z ⊖   (V); wherein M ⊕ is a cation selected from lithium, sodium, potassium, cesium, barium, ammonium and linear or branched tetra(C 1 -C 4 )alkyl ammonium; Z ⊖ is a weakly coordinating anion selected from B(C 6 F 5 ) 4 ⊖ , B[C 6 H 3 (CF 3 ) 2 ] 4 ⊖ , B(C 6 H 5 ) 4 ⊖ , [Al(OC(CF 3 ) 2 C 6 F 5 ) 4 ] ⊖ , BF 4 ⊖ , PF 6 ⊖ , AsF 6 ⊖ , SbF 6 ⊖ , (CF 3 SO 2 )N ⊖ and CF 3 SO 3 ⊖ . 9 . The composition of claim 8 , wherein said compound of the formula (V) is selected from the group consisting of: lithium tetrafluoroborate; lithium triflate; lithium tetrakis(pentafluorophenyl)borate; lithium tetraphenylborate; lithium tetrakis(3,5-bis(trifluoromethyl)phenyl)borate; lithium tetrakis(2-fluorophenyl)borate; lithium tetrakis(3-fluorophenyl)borate; lithium tetrakis(4-fluorophenyl)borate; lithium tetrakis(3,5-difluorophenyl)borate; lithium hexafluorophosphate; lithium hexaphenylphosphate; lithium hexakis(pentafluorophenyl)phosphate; lithium hexafluoroarsenate; lithium hexaphenylarsenate; lithium hexakis(pentafluorophenyl)arsenate; lithium hexakis(3,5-bis(trifluoromethyl)phenyl)arsenate; lithium hexafluoroantimonate; lithium hexaphenylantimonate; lithium hexakis(pentafluorophenyl)antimonate; lithium hexakis(3,5-bis(trifluoromethyl)phenyl)antimonate; lithium tetrakis(pentafluorophenyl)aluminate; lithium tris(nonafluorobiphenyl)fluoroaluminate; lithium (octyloxy)tris(pentafluorophenyl)aluminate; lithium tetrakis(3,5-bis(trifluoromethyl)phenyl)aluminate; and lithium methyltris(pentafluorophenyl)aluminate 10 . The composition of claim 1 , wherein said one or more monomer of formula (II) is selected from the group consisting of: bicyclo[2.2.1]hept-2-ene (NB); norbornenyl-2-trifluoromethyl-3,3,3-trifluoropropan-2-ol (HFANB); 5-hexylbicyclo-[2.2.1]hept-2-ene (HexNB); 5-octylbicyclo[2.2.1]hept-2-ene (OctNB); 5-decylbicyclo[2.2.1]hept-2-ene (DecNB); 5-perfluorobutylbicyclo[2.2.1]hept-2-ene (C 4 F 9 NB); 5-phenethylbicyclo[2.2.1]hept-2-ene (PENB); and 2-(bicyclo[2.2.1]hept-5-en-2-yl)bicyclo[2.2.1]heptane (NBANB). 11 . The composition of claim 1 , wherein said one or more monomers of formula (II) are at least two distinct types of monomers of formula (II). 12 . The composition of claim 1 , wherein at least one of said one or more monomers of formula (II) is 5-decylbicyclo[2.2.1]hept-2-ene (DecNB) or 5-hexylbicyclo-[2.2.1]hept-2-ene (HexNB). 13 . The composition of claim 1 , wherein at least one of said one or more monomers of formula (II) is 5-phenethylbicyclo[2.2.1]hept-2-ene (PENB). 14 . The composition of claim 1 , wherein said compound of formula (I) is present in an amount of at least one mole percent of the total loading of the monomers of formula (II). 15 . The composition of claim 1 , wherein said compound of formula (I) is present in an amount of from one to ten mole percent of the total loading of the monomers of formula (II). 16 . A method of mass polymerizing polycyclic olefin monomers comprising: combining a compound of formula (I): wherein a is an integer from 0 to 4; b is an integer from 0 to 2a+4; each R is hydrogen, halogen, methyl, ethyl, (C 3 -C 6 )alkyl, substituted or unsubstituted (C 3 -C 7 )cycloalkyl, (C 6 -C 10 )aryl, (C 6 -C 10 )aralkyl, methoxy, ethoxy, (C 3 -C 6 )alkoxy, sub

Assignees

Inventors

Classifications

  • C08F132/08Primary

    having condensed rings · CPC title

  • Polymerisation using regulators, e.g. chain terminating agents {, e.g. telomerisation} · CPC title

  • C08F2/02Primary

    Polymerisation in bulk · CPC title

  • of boron, aluminium, gallium, indium, thallium or rare earths · CPC title

  • PO · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016289353A1 cover?
The present invention relates to use of certain chain transfer agents to control molecular weight of addition mass polymerization of certain polycycloolefinic monomers. More specifically, the present invention relates to use of a series of substituted bicycloalkenes as chain transfer agents in the addition mass polymerization of a series of functionalized norbornene-type monomers. This inventio…
Who is the assignee on this patent?
Promerus Llc
What technology area does this patent fall under?
Primary CPC classification C08F132/08. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Oct 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).